Skip to main content
Log in

Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

The aim of the study was to report on the clinical utility of naturalistic adjunctive treatment with valproate (VPA) in a group of panic disorder (PD) patients with comorbid bipolar disorder (BD) or otherwise resistant to antidepressants. The hypothesis was that these patients might not respond because of coexisting low-grade mood instability and adjunctive VPA treatment might ameliorate PD symptoms. A group of 47 patients with lifetime comorbid BD (n = 35, 74.5%) or otherwise resistant to antidepressants (n = 12, 25.6%), from a population of 326 consecutive outpatients with PD-Agoraphobia evaluated and treated at the Psychiatric Institute of the University of Pisa from 1991 to 1995, and followed for a period of 3 years. All patients were evaluated at baseline and at least every 2 months by means of an intensive interview including semi-structured and structured instruments (SCID, Life-Up, and Panic Disorder/Agoraphobia Interview). Mean dosage was 687 (SD = 234) mg/day (min 400, max 1,500 mg/day). Adjunctive treatment with VPA was well tolerated by all subjects, and there was no treatment interruption because of side effects or adverse events. All antidepressants-resistant subjects and 31 of 35 (88.6%) patients with bipolar comorbidity achieved symptomatological remission. During the observation period, 7 (58.3%) among resistant subjects and 17 (48.6%) of bipolar patients had a relapse of panic disorder after remission. Survival analysis of remission durations and onset relapses for PD and Agoraphobia did not show significant differences between the two groups. Relapses of Agoraphobia were less frequent and more delayed than those for panic. According to the results, VPA seems to be an effective and a well-tolerated adjunctive treatment in PD patients who were resistant to antidepressant therapy or had BD in comorbidity. The results of the study support the hypothesis of resistance to antidepressant treatment being related to mood instability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Savino M, Perugi G, Simonini E, Soriani A, Cassano GB, Akiskal HS (1993) Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord 28:155–163

    Article  CAS  PubMed  Google Scholar 

  2. Bowen R, South M, Hawkes J (1994) Mood swings in patients with panic disorder. Can J Psychiatry 39(2):91–94

    CAS  PubMed  Google Scholar 

  3. Grunhaus L, Pande AC, Brown MB, Greden JF (1994) Clinical characteristics of patients with concurrent major depressive disorder and panic disorder. Am J Psychiatry 151(4):541–546

    CAS  PubMed  Google Scholar 

  4. Freeman MP, Freeman SA, McElroy SL (2002) The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology and treatment issues. J Affect Disord 68(1):1–23

    Article  PubMed  Google Scholar 

  5. Angold A, Costello EJ (1995) Developmental epidemiology. Epidemiol Rev 17(1):74–82

    CAS  PubMed  Google Scholar 

  6. Chen YW, Dilsaver SC (1995) Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey. Am J Psychiatry 152(2):280–282

    CAS  PubMed  Google Scholar 

  7. Shoaib AM, Dilsaver SC (1994–1995) Panic disorder in subjects with pure mania and depressive mania. Anxiety 1(6):302–304

    Google Scholar 

  8. Dilsaver SC, Chen YW, Swann AC, Shoaib AM, Tsai-Dilsaver Y, Krajewski KJ (1997) Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania. Psychiatry Res 14(73):47–56

    Article  Google Scholar 

  9. Craig T, Hwang MY, Bromet EJ (2002) Obsessive-compulsive and panic symptoms in patients with first-admission psychosis. Am J Psychiatry 159(4):592–598

    Article  PubMed  Google Scholar 

  10. MacKinnon DF, McMahon FJ, Simpson SG (1997) Panic Disorder with familial bipolar disorder. Biol Psychiatry 42:90–95

    Article  CAS  PubMed  Google Scholar 

  11. MacKinnon DF, Zandi PP, Cooper J (2002) Comorbid bipolar disorder and panic disorder in families with a high prevalence of bipolar disorder. Am J Psychiatry 159:30–35

    Article  PubMed  Google Scholar 

  12. Feske U, Frank E, Mallinger AG (2000) Anxiety as a correlate of response to the Acute Treatment of Bipolar I Disorder. Am J Psychiatry 157:956–962

    Article  CAS  PubMed  Google Scholar 

  13. Van Scheyen JD, van Kammen DP (1979) Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry 36(5):560–565

    PubMed  Google Scholar 

  14. Rhimer Z, Barsi J, Belso N (1996) Antidepressant induced hypomania in obsessive-compulsive disorder. Int Clin Psychopharm 11:203–205

    Article  Google Scholar 

  15. Himmelhoch JM (1998) Social anxiety, hypomania and the bipolar spectrum: Data, theory and clinical issues. J Affect Disord 50:203–213

    Article  CAS  PubMed  Google Scholar 

  16. Levy D, Kimhi R, Barak Y, Aviv A, Elizur A (1998) Antidepressant-associated mania: a study of anxiety disorders patients. Psychopharmacology 136(3):243–246

    Article  CAS  PubMed  Google Scholar 

  17. Van Putten T, Marder SR (1987) Behavioral toxicity of antipsychotic drugs. J Clin Psychiatry 48(1):13–19

    PubMed  Google Scholar 

  18. Argyle N (1990) Panic attacks in chronic schizophrenia. Br J Psychiatry 177:430–433

    Article  Google Scholar 

  19. Baker R, Chengappa KN, Baird JW (1992) Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53(12):439–442

    CAS  PubMed  Google Scholar 

  20. de Haan L, Beuk N, Hoogenboom B (1997) Obsessive-compulsive symptoms during treatment with olanzapine and risperidone : a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 58:119–122

    Google Scholar 

  21. Uhde TW, Post RM (1984) Carbamazepine in the treatment of neuropsychiatric disorder. In: Emrich HM (ed) Anticonvulsants in the treatment of affective illness. Excerpta Medica, Almere

    Google Scholar 

  22. Edlund MJ, Swann AC, Clothier J (1987) Patients with panic attacks and abnormal EEG results. Am J Psychiatry 144:508–509

    CAS  PubMed  Google Scholar 

  23. Primeau F, Fontaine R, Beauclair L (1990) Valproic acid and panic disorder. Can J Psychiatry 35:248–250

    CAS  PubMed  Google Scholar 

  24. Lum M, Fontaine R, Elie R (1991) Probable interaction of sodium valproate with benzodiazepines. Prog Neuropsychopharmacol Biol Psychiatry 15:269–273

    Article  CAS  PubMed  Google Scholar 

  25. Woodman CL, Noyes R (1994) Panic Disorder: treatment with valproate. J Clin Psychiatry 55:134–136

    CAS  PubMed  Google Scholar 

  26. Keck PE, Taylor VE, Tugrul KC (1993) Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 33:542–546

    Article  PubMed  Google Scholar 

  27. Baetz M, Bowen RC (1998) Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy. Can J Psychiatry 43(1):73–77

    CAS  PubMed  Google Scholar 

  28. Akiskal HS, Mallya G (1987) Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol Bull 23(1):68–73

    CAS  PubMed  Google Scholar 

  29. Toni C, Cassano GB, Perugi G, Murri L, Mancino M, Petracca A et al. (1996) Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy. Comprehensive Psychiatry 37(2)

  30. Keller M, Lavori P, Friedman B (1987) The longitudinal Interval Follow-up Evaluation. A Comprehensive Method for assessing outcome in perspective longitudinal studies. Arch Gen Psychiatry 44:540–548

    CAS  PubMed  Google Scholar 

  31. Katschnig H, Amering M, Stolk JM (1995) Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 167:487–494

    Article  CAS  PubMed  Google Scholar 

  32. Guy W (1976) Adult Personal Data Inventory. In: Guy W (ed) ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, pp 93–107

  33. Andreasen NC, Endicott J, Spitzer RL, Winokur G (1977) The family history method using diagnostic criteria. Arch Gen Psychiatry 34(10):1229–1235

    CAS  PubMed  Google Scholar 

  34. Placidi GF, Signoretta A, Liguori A, Gervasi R, Maremmani I, Akiskal HS (1998) The semi- structured affective temperament interview (TEMPS-I). Reliability and psychometric properties in 1010 14–26 year old students. J Affect Disord 47(1–3):1–10

    Article  CAS  PubMed  Google Scholar 

  35. Spitzer RL, Williams JBW, Gibbon M, First MB (eds) (1990) Structured Clinical Interview for DSM-III-R personality Disorders (SCID-II). Washington

  36. Lecrubier Y, Judge R (1997) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95(2):145–152

    Article  CAS  PubMed  Google Scholar 

  37. Perugi G, Toni C, Akiskal HS (1999) Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am 22(3):565–583

    Article  CAS  PubMed  Google Scholar 

  38. McElroy SL, Altshuler LL, Suppes T, Keck PEJ, Frye MA, Denicoff KD et al (2001) Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 158(3):420–426

    Article  CAS  PubMed  Google Scholar 

  39. Angst J, Gamma A, Endrass J, Hantouche E, Goodwin R, Ajdacic V et al (2005) Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Eur Arch Psychiatry Clin Neurosci 255(1):65–71

    Article  PubMed  Google Scholar 

  40. Angst J, Gamma A, Endrass J, Rossler W, Ajdacic-Gross V, Eich D et al (2006) Is the association of alcohol use disorders with major depressive disorder a consequence of undiagnosed bipolar-II disorder? Eur Arch Psychiatry Clin Neurosci 256(7):452–457

    Article  PubMed  Google Scholar 

  41. Endrass J, Vetter S, Gamma A, Gallo WT, Rossegger A, Urbaniok F et al (2007) Are behavioral problems in childhood and adolescence associated with bipolar disorder in early adulthood? Eur Arch Psychiatry Clin Neurosci 257(4):217–221

    Article  PubMed  Google Scholar 

  42. Zutshi A, Janardhan Reddy YC, Thennarasu K, Chandrashekhar CR (2006) Comorbidity of anxiety disorders in patients with remitted bipolar disorder. Eur Arch Psychiatry Clin Neurosci 256(7):428–436

    Article  CAS  PubMed  Google Scholar 

  43. Angst J, Gamma A, Benazzi F, Ajdacic V, Rossler W (2009) Does psychomotor agitation in major depressive episodes indicate bipolarity? Evidence from the Zurich Study. Eur Arch Psychiatry Clin Neurosci 259(1):55–63

    Article  PubMed  Google Scholar 

  44. Moller HJ (2008) The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European Psychiatric tradition. Eur Arch Psychiatry Clin Neurosci 258(5):7–17

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giulio Perugi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perugi, G., Frare, F., Toni, C. et al. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year “open” follow-up study. Eur Arch Psychiatry Clin Neurosci 260, 553–560 (2010). https://doi.org/10.1007/s00406-010-0109-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-010-0109-y

Keywords

Navigation